A multifaceted campaign to encourage hospital staff to get seasonal flu shots boosted coverage past the 80% mark for workers involved with direct patient care, researchers said.
No Comments »
Filed under: General Health News
Helix BioPharma Corp. (TSX, FSE: HBP; Pink Sheets: HXBPF) announced that the first ten patients that have been enrolled in its Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions have completed the pharmacokinetic primary endpoint analyses with positive findings…
No Comments »
Filed under: Pharmacy News
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population…
No Comments »
Filed under: Pharmacy News
Daiichi Sankyo, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment Benicar® (olmesartan medoxomil) for use in children and adolescents 6 to 16 years of age.(1) Benicar was originally approved in 2002 for the treatment of hypertension in adults. Approximately 5 percent or 3…
No Comments »
Filed under: Pharmacy News
Novartis has gained exclusive rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent currently in Phase IIb development for the treatment of hepatitis C. Debio 025 is the first in a new class of drugs called cyclophilin inhibitors which could become part of the future standard of care for the disease…
No Comments »
Filed under: Pharmacy News
Breast cancer rates are declining, but some groups have seen a more significant decline than others, with race, ethnicity and economic background playing a part…
No Comments »
Filed under: Women's Health
For women concerned about heart disease, routine testing of high-sensitivity C-reactive protein (hs-CRP) is controversial, says Thomas Behrenbeck, M.D., Ph.D., a Mayo Clinic cardiologist, in an interview in the February issue of Mayo Clinic Women’s HealthSource. CRP is a marker for inflammation within the body and has been promoted as a screening test [...]
No Comments »
Filed under: Women's Health
Pelvic health concerns in women are common — yet how the issues impact sexuality and childbearing is not often discussed, according to Mayo Clinic Women’s HealthSource. The February issue features an overview of pelvic health problems, risk factors, causes and treatment options…
No Comments »
Filed under: Women's Health
A Henry Ford Hospital study finds women with type 2 diabetes who take a commonly prescribed class of medications to treat insulin resistance may be at a higher risk for developing bone fractures. After taking a thiazolidinedione (TZD) for one year, women are 50 percent more likely to have a bone fracture than patients not [...]
No Comments »
Filed under: Women's Health
Despite strides in raising awareness of cardiovascular disease as the leading cause of death and illness among women, heart disease is still under-recognized, under-treated, and under-diagnosed in women. During American Heart Month, The American College of Obstetricians and Gynecologists encourages women to learn how they can protect their heart health…
No Comments »
Filed under: Women's Health
